Original Research
Published on 16 Dec 2022
Canagliflozin promotes osteoblastic MC3T3-E1 differentiation via AMPK/RUNX2 and improves bone microarchitecture in type 2 diabetic mice
in Bone Research
Frontiers in Endocrinology
doi 10.3389/fendo.2022.1081039
- 7,943 views
- 18 citations


